Cargando…

Clinical Interventions for Late-Life Anxious Depression

Anxiety symptoms are frequently present in patients with late-life depression. The designation “anxious depression” has been used to describe major depressive disorder (MDD) accompanied by clinically significant but subsyndromal anxiety symptoms. MDD may also present comorbid with diagnosable anxiet...

Descripción completa

Detalles Bibliográficos
Autores principales: Diefenbach, Gretchen J, Goethe, John
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682453/
https://www.ncbi.nlm.nih.gov/pubmed/18047256
_version_ 1782167057827102720
author Diefenbach, Gretchen J
Goethe, John
author_facet Diefenbach, Gretchen J
Goethe, John
author_sort Diefenbach, Gretchen J
collection PubMed
description Anxiety symptoms are frequently present in patients with late-life depression. The designation “anxious depression” has been used to describe major depressive disorder (MDD) accompanied by clinically significant but subsyndromal anxiety symptoms. MDD may also present comorbid with diagnosable anxiety disorders, although this presentation is less common in late life. Diagnosis of anxious depression in the elderly is complicated by several factors (eg, their tendency to experience and report psychiatric symptoms as somatic illness) and is associated with a more severe clinical presentation, increased risk for suicidal ideation, increased disability, and poorer prognosis. Standard pharmacotherapy for depression may be sufficient but for many patients must be modified or augmented. Psychosocial interventions may also be an important component in the treatment of these patients, although no specific psychosocial treatments have been developed for late-life anxious depression.
format Text
id pubmed-2682453
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-26824532009-06-16 Clinical Interventions for Late-Life Anxious Depression Diefenbach, Gretchen J Goethe, John Clin Interv Aging Review Anxiety symptoms are frequently present in patients with late-life depression. The designation “anxious depression” has been used to describe major depressive disorder (MDD) accompanied by clinically significant but subsyndromal anxiety symptoms. MDD may also present comorbid with diagnosable anxiety disorders, although this presentation is less common in late life. Diagnosis of anxious depression in the elderly is complicated by several factors (eg, their tendency to experience and report psychiatric symptoms as somatic illness) and is associated with a more severe clinical presentation, increased risk for suicidal ideation, increased disability, and poorer prognosis. Standard pharmacotherapy for depression may be sufficient but for many patients must be modified or augmented. Psychosocial interventions may also be an important component in the treatment of these patients, although no specific psychosocial treatments have been developed for late-life anxious depression. Dove Medical Press 2006-03 2006-03 /pmc/articles/PMC2682453/ /pubmed/18047256 Text en © 2006 Dove Medical Press Limited. All rights reserved
spellingShingle Review
Diefenbach, Gretchen J
Goethe, John
Clinical Interventions for Late-Life Anxious Depression
title Clinical Interventions for Late-Life Anxious Depression
title_full Clinical Interventions for Late-Life Anxious Depression
title_fullStr Clinical Interventions for Late-Life Anxious Depression
title_full_unstemmed Clinical Interventions for Late-Life Anxious Depression
title_short Clinical Interventions for Late-Life Anxious Depression
title_sort clinical interventions for late-life anxious depression
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2682453/
https://www.ncbi.nlm.nih.gov/pubmed/18047256
work_keys_str_mv AT diefenbachgretchenj clinicalinterventionsforlatelifeanxiousdepression
AT goethejohn clinicalinterventionsforlatelifeanxiousdepression